CAS: 199463-33-7 - Revaprazan
Formula:C22H23FN4
InChI:InChI=1S/C22H23FN4/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3/h4-11,16H,12-13H2,1-3H3,(H,24,25,26)
InChI key:InChIKey=LECZXZOBEZITCL-UHFFFAOYSA-N
SMILES:FC1=CC=C(C=C1)NC=2N=C(C(=C(N2)C)C)N3CCC=4C=CC=CC4C3C
- Synonyms:
- Revaprazan
- 4-(3,4-Dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine
- YH 1885 free base
- 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-
- SB 641257
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Revaprazan REF: IN-DA00BHJSCAS: 199463-33-7 | 99% | To inquire | Tue 07 Jan 25 |
 | Revaprazan REF: TM-T20660CAS: 199463-33-7 | 98% | 1,418.00 €~2,325.00 € | Tue 14 Jan 25 |
 | Revaprazan REF: 3D-ZHA46333CAS: 199463-33-7 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00BHJS
| 5mg | 121.00 € | ||
| 25mg | 306.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Revaprazan
CAS:199463-33-7
Revaprazan: novel, K⁺-competitive acid blocker; reversibly halts gastric H⁺/K⁺-ATPase; rivals PPIs in acid reduction.
Formula:
C22H23FN4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
362.44
Ref: TM-T20660
| 25mg | 1,418.00 € | ||
| 50mg | 1,832.00 € | ||
| 100mg | 2,325.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Revaprazan
CAS:199463-33-7
Revaprazan hydrochloride is the salt form of Revaprazan which is concentrated in the gastric parietal …
Formula:
C22H23FN4
Purity:
Min. 95%
Molecular weight:
362.4 g/mol
Ref: 3D-ZHA46333
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
